Frontiers in Bioengineering and Biotechnology · 2022 · 11 citations · 32 references
MedicineBiotechnologyOncologyBiosensorsMolecular DiagnosticsMolecular OncologyAptamer-based BiosensorsCancer BiomarkersCancer NanomedicineExosome AnalysisNanomaterial-based BiosensorsNanomedicineAptamersEarly ScreeningExosomal BiomarkersExosome-based Disease DiagnosticsExosomesExosomes In CancerFluorescent SensingTumor-derived Exosomes
Traditional detection methods for protein tumor markers in the early screening of breast cancer are restricted by complicated operation procedures and unstable reproducibility. As one of alternative emerging tumor markers, exosomes play an important role in diagnosing and treating cancers at the early stage due to traceability of their origins and great involvement in occurrence and development of cancers. Herein, a washing-free and efficient fluorescent biosensor has been proposed to realize simple and straightforward analysis of breast cancer cell-derived exosomes based on high affinity aptamers and G quadruplex-hemin (G4-hemin). The whole reaction process can be completed by several simple steps, which realizes washing-free and labor-saving. With simplified operation procedures and high repeatability, the linear detection range for this developed fluorescent biosensing strategy to breast cancer cell-derived exosomes is from 2.5 × 10 5 to 1.00 × 10 7 particles/ml, and the limit of detection is down to 0.54 × 10 5 particles/ml.
32
Clotilde Théry, Kenneth W. Witwer, Elena Aïkawa et al. · Journal of Extracellular Vesicles · 2018 · 11.2K citations · Full text
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
Yiran Liang, Xiaojin Song, Yaming Li et al. · Molecular Cancer · 2020 · 396 citations · Full text
Medicine, Cancer Biology, Oncology +17
λ-DNA- and Aptamer-Mediated Sorting and Analysis of Extracellular Vesicles
Chao Liu, Junxiang Zhao, Fei Tian et al. · Journal of the American Chemical Society · 2019 · 261 citations